Freeline Therapeutics Holdings (FRLN)
NASDAQ:FRLN
Holding FRLN?
Track your performance easily

Freeline Therapeutics Holdings (FRLN) Financial Statements

210 Followers

Freeline Therapeutics Holdings Financial Overview

Freeline Therapeutics Holdings's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Freeline Therapeutics Holdings is scheduled to report earnings on March 28, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -18.02M$ -22.93M$ -26.56M$ -27.79M$ -31.40M
EBITDA$ -17.70M$ -22.52M$ -26.08M$ -27.24M$ -30.79M
Net Income Common Stockholders$ -23.00M$ -14.89M$ -24.35M$ -26.73M$ -34.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 47.28M$ 65.85M$ 90.00M$ 113.10M$ 117.66M
Total Assets$ 86.64M$ 100.08M$ 162.13M$ 196.17M$ 141.13M
Total Debt$ 5.92M$ 11.96M$ 57.41M$ 59.63M$ 0.00
Net Debt$ -41.35M$ -53.89M$ -32.59M$ -53.47M$ -117.66M
Total Liabilities$ 34.23M$ 31.49M$ 72.50M$ 77.61M$ 20.68M
Stockholders Equity$ 52.41M$ 68.58M$ 89.63M$ 118.56M$ 120.44M
Cash Flow-
Free Cash Flow$ -23.75M$ -17.35M$ -17.03M$ -27.11M$ -17.93M
Operating Cash Flow$ -19.85M$ -15.17M$ -16.62M$ -26.58M$ -17.29M
Investing Cash Flow$ -3.90M$ -2.18M$ -413.00K$ -526.00K$ -636.00K
Financing Cash Flow$ 88.00K$ -3.00K$ 2.19M$ 25.25M$ -1.09M
Currency in USD

Freeline Therapeutics Holdings Earnings and Revenue History

Freeline Therapeutics Holdings Debt to Assets

Freeline Therapeutics Holdings Cash Flow

Freeline Therapeutics Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis